Addition of Manidipine Improves the Antiproteinuric Effect of Candesartan in Hypertensive Patients With Type II Diabetes and Microalbuminuria | Zendy

R Fogari | Zendy; Luca Corradi | Zendy; Annalisa Zoppi | Zendy; P. Lazzari | Zendy; Amedeo Mugellini | Zendy; Paola Preti | Zendy; Andrea Rinaldi | Zendy

Open Access

Addition of Manidipine Improves the Antiproteinuric Effect of Candesartan in Hypertensive Patients With Type II Diabetes and Microalbuminuria

Author(s) -

R Fogari,

Luca Corradi,

Annalisa Zoppi,

P. Lazzari,

Amedeo Mugellini,

Paola Preti,

Andrea Rinaldi

Publication year - 2007

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1016/j.amjhyper.2007.05.012

Subject(s) - candesartan , medicine , microalbuminuria , hydrochlorothiazide , blood pressure , urology , endocrinology , glycated hemoglobin , type 2 diabetes , diabetes mellitus , angiotensin ii

We sought to compare the effect of manidipine versus hydrochlorothiazide (HCTZ) in addition to candesartan on the urinary albumin excretion rate (UAER) in hypertensive patients with type II diabetes and microalbuminuria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research